Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.
about
Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of In Vitro StudiesPhysicochemical signatures of nanoparticle-dependent complement activation.Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.Tunable Luminescent Carbon Nanospheres with Well-Defined Nanoscale Chemistry for Synchronized Imaging and Therapy.Synthesis of Self-Assembled Spermidine-Carbon Quantum Dots Effective against Multidrug-Resistant Bacteria.Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis.Materials design at the interface of nanoparticles and innate immunity.Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy.Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.Role of Surface Hydrophobicity of Dicationic Amphiphile-Stabilized Gold Nanoparticles on A549 Lung Cancer Cells.Main trends of immune effects triggered by nanomedicines in preclinical studiesMonitoring the Hemolytic Effect of Mesoporous Silica Nanoparticles after Human Blood Protein Corona FormationAnti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
P2860
Q29248759-19234577-E7BC-46AB-A9CD-902EBF125579Q34218533-C4CE1C52-4A59-4C9B-8C02-72E68FFCAC9BQ35317271-F9BC32E8-46DA-490F-8898-AA30C5183F5FQ38872815-3F6E300B-54CB-4847-A538-4E306B4674ABQ40603240-0138F751-30A2-4E92-BFA1-23E9BA60B8C4Q41860441-FCDCD721-EEA2-48E5-866B-8066B0F7E6A3Q41915826-328B6DDC-EFE4-43AD-A30F-0354DF66E241Q42124938-2438323F-684F-4BA8-AE29-10C94C507969Q55348014-3CF35D15-7110-4CCC-B044-5AEE41E3F691Q55689542-F25000CB-1FD8-4D78-9B7D-AA63CB1E3AB1Q57074417-0A76E87D-493F-4E15-9EE6-292E1FEAB3FFQ57640531-92E894EB-7DE5-496B-8B24-7C4CACEDA3ABQ58761484-67429786-92ED-49E6-BAB0-30E0B8C2F2C9
P2860
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@en
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@nl
type
label
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@en
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@nl
prefLabel
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@en
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@nl
P2093
P2860
P1476
Application of a hemolysis ass ...... perfluorocarbon nanoparticles.
@en
P2093
Angana Senpan
Christine T N Pham
Dennis E Hourcade
Dennis G Thomas
Gregory M Lanza
Jennifer L Huang
Julia Beiser
Lynne M Mitchell
Mae Gordon
P2860
P304
P356
10.1016/J.NANO.2013.10.012
P577
2013-11-08T00:00:00Z